Home › All Companies › WHWK › Insider Trading

Whitehawk Therapeutics, Inc. (WHWK) — Insider Trading

AI-Powered SEC Filing Analysis

← All WHWK filings
Latest Insider Trading Filed: 2026-04-10

Key Insights

  • The CEO, David James Lennon, sold 14,500 shares of Whitehawk Therapeutics, Inc. (WHWK) at $3.38 per share, potentially indicating some near-term selling pressure on the stock.
  • Lennon continues to hold a significant stake of 518,622 shares in the company, suggesting he maintains a positive long-term outlook.
  • The sale appears to be a routine transaction to cover tax withholding obligations related to the vesting of restricted stock units, rather than a broader change in the CEO's investment position.
Sentiment: Neutral Significance: 4/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-04-10. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.